Publikation
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.
Wissenschaftlicher Artikel/Review - 19.10.2023
O'Dowd Emma L, Tietzova Ilona, Bartlett Emily, Devaraj Anand, Biederer Jürgen, Brambilla Marco, Brunelli Alessandro, Chorostowska-Wynimko Joanna, Decaluwe Herbert, Deruysscher Dirk, De Wever Walter, Donoghue Matthew, Fabre Aurelie, Gaga Mina, van Geffen Wouter, Hardavella Georgia, Kauczor Hans-Ulrich, Kerpel-Fronius Anna, van Meerbeeck Jan P, Nagavci Blin, Nestle Ursula, Novoa Nuria, Prosch Helmut, Prokop Mathias, Putora Paul Martin, Rawlinson Janette, Revel Marie-Pierre, Snoeckx Annemiek, Veronesi Giulia, Vliegenthart Rozemarijn, Weckbach Sabine, Blum Torsten G, Baldwin David
Bereiche
PubMed
DOI
Kontakt
Zitation
Art
Zeitschrift
Veröffentlichungsdatum
eISSN (Online)
Kurzbeschreibung/Zielsetzung
Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that will ensure clinical and cost effectiveness. This European Respiratory Society (ERS) task force was formed to provide an expert consensus for the management of incidental findings which can be adapted and followed during implementation.